Advances in Glucocorticoid-Induced Osteoporosis
- Debby den UylAffiliated withDepartment of Rheumatology, VU University Medical Center
- , Irene E. M. BultinkAffiliated withDepartment of Rheumatology, VU University Medical Center
- , Willem F. LemsAffiliated withDepartment of Rheumatology, VU University Medical Center Email author
Glucocorticoid-induced osteoporosis (GIOP) is one of the most important side effects of glucocorticoid use, as it leads to an increased risk of fractures. Recently, many published studies have focused on the cellular and molecular mechanisms of bone metabolism, the pathophysiology of GIOP, and the intervention options to prevent GIOP. In this review, recent advances in GIOP are summarized, particularly recent progress in our understanding of the mechanisms of GIOP resulting in improved insight that might result in the development of new treatment options in the near future.
KeywordsBone Glucocorticoids Osteoporosis
- Advances in Glucocorticoid-Induced Osteoporosis
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Current Rheumatology Reports
Volume 13, Issue 3 , pp 233-240
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Industry Sectors